IO Biotech, Inc. (IOBTQ)

IO Biotech, Inc. has filed 269 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
SC 13D/A 2026-06-02 Beneficial Ownership Report (Amended)
SC 13G/A 2026-05-20 Beneficial Ownership Report (Passive, Amended)
SC 13G/A 2026-05-15 Beneficial Ownership Report (Passive, Amended)
SCHEDULE 13G/A 2026-04-06 SCHEDULE 13G/A
8-K 2026-03-31 Bankruptcy or Receivership; Triggering Events That Accelerate Financial Obligations
SCHEDULE 13G/A 2026-02-13 SCHEDULE 13G/A
8-K 2026-02-13 Notice of Delisting or Transfer
SCHEDULE 13G 2026-02-06 SCHEDULE 13G
8-K 2026-01-30 Costs Associated with Exit or Disposal Activities; Departure/Appointment of Directors or Officers
SCHEDULE 13D/A 2026-01-23 SCHEDULE 13D/A